TrialThe lancet. Diabetes & endocrinology2019

Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial.

Joy N Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.